Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

Innospec (IOSP) stock in plain English

Free brief · no signupStart here
IOSPPublished Nov 15, 2026
Innospec Inc
Basic Materials · Specialty Chemicals
Produces specialty additives for aviation, marine, and road fuels to improve engine performance and reduce emissions.
Assets:
Global manufacturing networkOperates specialty chemical production plants across the United States, United Kingdom, Germany, and Spain.
Workforce scaleEmploys over 2,200 people across more than twenty countries.
Technology centersMaintains major research facilities in Cheshire, Delaware, and Herne to formulate specialty chemicals.
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

73
OPS ScoreOperating finances
Latest quote
-2.26%$77.08
$1.90B
13.6×
$1.88B

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 15, 2026Quotes updated Nov 20, 04:00 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was IOSP. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does Innospec (IOSP) do?

Innospec Inc (IOSP) is a U.S.-listed company in Basic Materials (Specialty Chemicals). What it does: Produces specialty additives for aviation, marine, and road fuels to improve engine performance and reduce emissions. Manufactures custom chemical additives that improve fuel efficiency, personal care formulations, and oilfield. It is worth $1.90B on the market and sold $1.88B over the last year.

Market cap
$1.90B
P/E ratio
13.6×
Annual sales
$1.88B
Sector
Basic Materials
Industry
Specialty Chemicals
Brief updated
Nov 15, 2026

Brands and businesses behind IOSP

  • Stadis: Produces conductivity additives used globally in jet fuels to prevent hazardous static discharge during pumping.
  • Pureact: Formulates mild surfactants used in cleansers, shampoos, and personal hygiene products to generate lather.
  • Isel: Manufactures customized synthetic lubricants for industrial air compressors, refrigeration systems, and manufacturing equipment.
  • Empicol: Produces surfactant solutions sold to consumer packaged goods manufacturers for shampoos, body washes, and detergents.

IOSP’s flags, in plain English

Each flag is a number from Innospec’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 15, 2026.

Low debt

Low debt, only 3% of shareholder equity. The company owes very little compared with what it earns, so a bad year is less likely to force its hand.

Stupid Cash

Can pay this year's bills 3 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.

Still Climbing

Sales up 8.3% a year over 5 years. Sales are higher than a year ago. Growth does not guarantee profit, so look at the margins too.

Thinly Traded

Thinly traded, about 228 shares a day, so prices can swing. Few shares change hands each day, so the price can jump on small orders and buying or selling can cost more.

2 more green flags and 1 more risk note open with the free trial. Try it free for 7 days.

Questions about IOSP

How big is Innospec?

Innospec’s market cap is $1.90B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $1.88B: what customers paid the company over the last year, before any costs.

What is IOSP’s P/E ratio?

IOSP’s P/E ratio is 13.6×. Investors pay about 13.6 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.

What could go wrong with IOSP?

A significant portion of revenue depends on transport fuel and oil extraction markets that face regulatory pressure to decarbonize. That is one risk on Innospec’s card. Its first risk flag is Thinly Traded, explained above. The card holds 1 more risk note for trial accounts. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From Innospec’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. IOSP’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card